mTNBC

July 16, 2020July 16, 2020

Trodelvy Better Than Chemo at Prolonging Survival in Advanced TNBC, Trial Shows

News

Immunomedics has announced that its Phase 3 ASCENT trial of Trodelvy (sacituzumab govitecan) met its main goal of demonstrating that the medication is superior to standard chemotherapy at delaying disease ... Read more

April 2, 2020April 2, 2020

CytoDyn Seeks Preliminary FDA Meeting on Leronlimab’s Breakthrough Therapy Status

News

After a recommendation from the U.S. Food and Drug Administration (FDA), CytoDyn is planning to ask the regulatory agency for a preliminary meeting to discuss the granting of breakthrough therapy status ... Read more